Abbott Laboratories Operating Income 2010-2025 | ABT

Abbott Laboratories annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Abbott Laboratories operating income for the quarter ending March 31, 2025 was $1.693B, a 22.15% increase year-over-year.
  • Abbott Laboratories operating income for the twelve months ending March 31, 2025 was $7.132B, a 12.23% increase year-over-year.
  • Abbott Laboratories annual operating income for 2024 was $6.825B, a 5.36% increase from 2023.
  • Abbott Laboratories annual operating income for 2023 was $6.478B, a 22.53% decline from 2022.
  • Abbott Laboratories annual operating income for 2022 was $8.362B, a 0.75% decline from 2021.
Abbott Laboratories Annual Operating Income
(Millions of US $)
2024 $6,825
2023 $6,478
2022 $8,362
2021 $8,425
2020 $5,357
2019 $4,532
2018 $3,650
2017 $1,564
2016 $3,026
2015 $2,867
2014 $2,599
2013 $2,133
2012 $1,360
2011 $1,629
2010 $6,088
2009 $6,236
Abbott Laboratories Quarterly Operating Income
(Millions of US $)
2025-03-31 $1,693
2024-12-31 $1,911
2024-09-30 $1,859
2024-06-30 $1,669
2024-03-31 $1,386
2023-12-31 $1,780
2023-09-30 $1,647
2023-06-30 $1,542
2023-03-31 $1,509
2022-12-31 $1,304
2022-09-30 $1,770
2022-06-30 $2,376
2022-03-31 $2,912
2021-12-31 $2,378
2021-09-30 $2,546
2021-06-30 $1,392
2021-03-31 $2,109
2020-12-31 $2,432
2020-09-30 $1,495
2020-06-30 $672
2020-03-31 $758
2019-12-31 $1,389
2019-09-30 $1,198
2019-06-30 $1,206
2019-03-31 $739
2018-12-31 $1,165
2018-09-30 $995
2018-06-30 $882
2018-03-31 $608
2017-12-31 $651
2017-09-30 $769
2017-06-30 $386
2017-03-31 $-242
2016-12-31 $789
2016-09-30 $897
2016-06-30 $816
2016-03-31 $524
2015-12-31 $815
2015-09-30 $713
2015-06-30 $729
2015-03-31 $610
2014-12-31 $829
2014-09-30 $728
2014-06-30 $677
2014-03-31 $365
2013-12-31 $418
2013-09-30 $473
2013-06-30 $627
2013-03-31 $615
2012-12-31 $-23
2012-09-30 $310
2012-06-30 $564
2012-03-31 $509
2011-12-31 $2,082
2011-09-30 $595
2011-06-30 $1,773
2011-03-31 $1,301
2010-12-31 $1,830
2010-09-30 $1,181
2010-06-30 $1,606
2010-03-31 $1,470
2009-12-31 $1,864
2009-09-30 $1,640
2009-06-30 $1,671
2009-03-31 $1,061
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $232.634B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.531B 38.19
Stryker (SYK) United States $145.427B 30.41
EssilorLuxottica (ESLOY) France $127.535B 0.00
Medtronic (MDT) Ireland $109.709B 15.55
Haleon (HLN) United Kingdom $49.754B 28.33
Lonza Group Ag (LZAGY) Switzerland $49.468B 0.00
ResMed (RMD) United States $36.224B 27.21
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Agilent Technologies (A) United States $32.148B 20.88
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.748B 89.29
Koninklijke Philips (PHG) Netherlands $21.431B 15.40
Zimmer Biomet Holdings (ZBH) United States $18.172B 11.67
Baxter (BAX) United States $15.441B 11.53
Smith & Nephew SNATS (SNN) United Kingdom $12.754B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.002B 20.89
Lantheus Holdings (LNTH) United States $5.375B 13.56
Prestige Consumer Healthcare (PBH) United States $4.194B 18.74
Perrigo (PRGO) Ireland $3.646B 9.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.048B 14.09
LeMaitre Vascular (LMAT) United States $1.872B 41.85
AtriCure (ATRC) United States $1.719B 0.00
Neogen (NEOG) United States $1.302B 16.67
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.110B 24.97
BioLife Solutions (BLFS) United States $1.016B 0.00
Kestra Medical Technologies (KMTS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.986B 12.60
InMode (INMD) Israel $0.930B 9.37
Evolus (EOLS) United States $0.642B 0.00
CeriBell (CBLL) United States $0.612B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.519B 0.00
Owens & Minor (OMI) United States $0.517B 4.29
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.326B 11.98
Aurora Cannabis (ACB) Canada $0.302B 53.70
Cresco Labs (CRLBF) United States $0.277B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.63
Sanara MedTech (SMTI) United States $0.259B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanuwave Health (SNWV) United States $0.242B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Verano Holdings (VRNOF) United States $0.216B 0.00
Quanterix (QTRX) United States $0.211B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Biote (BTMD) United States $0.194B 5.46
Brainsway (BWAY) Israel $0.192B 50.95
High Tide (HITI) Canada $0.185B 0.00
Omeros (OMER) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.81
Organigram Global (OGI) Canada $0.178B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.135B 16.58
Jin Medical (ZJYL) China $0.122B 0.00
TerrAscend (TSNDF) Canada $0.098B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Veru (VERU) United States $0.090B 0.00
Fonar (FONR) United States $0.090B 11.62
Agape ATP (ATPC) $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
InterCure (INCR) Israel $0.070B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.037B 12.94
Nephros (NEPH) United States $0.035B 46.71
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00